Prediction of molecular subtypes in acute myeloid leukemia based on gene expression profiling

Roeland Verhaak(Broad Institute), Peter J.M. Valk(Erasmus MC Cancer Institute), Claudia Erpelinck-Verschueren(Erasmus MC), Bob Löwenberg(Unknown), Bas J. Wouters(Erasmus MC), H. Berna Beverloo(Erasmus MC), Sanne Lugthart(St. Jude Children's Research Hospital), R Delwel(Erasmus University Rotterdam), Sakina Abbas(Erasmus MC)

Haematologica

October 6, 2008

10.3324/haematol.13299

Cited by 364

Related Papers

Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel

|Blood|2016|5.9k

Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet

|Blood|2009|3.4k

Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN

|Blood|2022|3.1k

Comprehensive molecular characterization of urothelial bladder carcinoma

|Nature|2014|3.1k

International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data

|Blood|2022|2.8k